{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:18:04Z","timestamp":1648847884262},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.arbres.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T20:57:01Z","timestamp":1520974621000},"page":"484-486","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tratamiento de la infecci\u00f3n tuberculosa latente en una unidad cl\u00ednica de tuberculosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Mar\u00eda \u00c1ngeles","family":"Jim\u00e9nez-Fuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Mil\u00e0 Aug\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Solsona Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luiza","family":"de Souza-Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2018.01.015_bib0070","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: WHO; 2015 [consultado 10 Ene 2018]. Disponible en: htpp:\/\/who.int\/tb\/publications\/ltbi_document_page\/en\/"},{"key":"10.1016\/j.arbres.2018.01.015_bib0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: A network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.arbres.2018.01.015_bib0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12879-016-1550-y","article-title":"Initiation and completion rates for latent tuberculosis infection treatment: A systematic review","author":"Sandgren","year":"2016","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.arbres.2010.02.010","article-title":"Documento de consenso sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de la tuberculosis","volume":"46","author":"Gonz\u00e1lez-Mart\u00edn","year":"2010","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2018.01.015_bib0090","first-page":"587","article-title":"A new method for the determination of N-acetyl isoniazid in urine of ambulatory patiens","volume":"89","author":"Eidus","year":"1964","journal-title":"Am Rev Respir Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0095","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2018.01.015_bib0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5588\/ijtld.12.0510","article-title":"Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population","volume":"17","author":"Jim\u00e9nez-Fuentes","year":"2013","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-016-1549-4","article-title":"Interventions for improving adherence to treatment for latent tuberculosis infection: A systematic review","author":"Stuurman","year":"2016","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jinf.2013.07.015","article-title":"Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosis","volume":"67","author":"Pettit","year":"2013","journal-title":"J Infect."},{"key":"10.1016\/j.arbres.2018.01.015_bib0115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: Hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2018.01.015_bib0120","first-page":"1374","article-title":"Age-related risk of hepatatoxicity in the treatment of latent tuberculosis infection: A systematic rewiew","volume":"14","author":"Kunst","year":"2010","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0125","first-page":"1104","article-title":"Predictors of latent tuberculosis infection treatment completion in the United States: An innercity experience","volume":"14","author":"Hirsch-Moverman","year":"2010","journal-title":"Int J Tuberc Lung Dis."},{"key":"10.1016\/j.arbres.2018.01.015_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U. S. public health clinic: A prospective cohort study","volume":"12","author":"Goswami","year":"2012","journal-title":"BMC Public Health."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T08:13:44Z","timestamp":1535789624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289618300309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0300289618300309"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2018.01.015","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento de la infecci\u00f3n tuberculosa latente en una unidad cl\u00ednica de tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}